⚠ For research purposes only — not for human consumption. Not evaluated by the FDA.
Retatrutide
20mg
Retatrutide is a triple receptor agonist (GLP-1/GIP/glucagon) studied in preclinical and clinical metabolic research models for effects on metabolic pathways and body composition.
How to Order
Preclinical Research Areas
- ●Studied in metabolic pathway research
- ●Investigated in preclinical body composition models
- ●GLP-1/GIP/glucagon receptor mechanism studies
- ●Published Phase 2 and Phase 3 clinical research data
Published research literature covers this compound across multiple study designs and research contexts. Refer to peer-reviewed publications for study methodology and findings. This information is provided strictly for research reference — not for human use.
⚠ This information is from published scientific literature and is provided strictly for research reference. Not for human use. Follow all applicable laws and institutional protocols.
Multiple Phase 2 and Phase 3 trials published. One of the most studied GLP-1 triple agonists to date.
📊 Independent verification. Each report below is issued by a third-party analytical laboratory. Results confirm compound identity and purity. Documents are provided for research transparency only.
- Every order includes a Certificate of Analysis (CoA) from a third-party lab
- Ships within 1–2 business days from Wichita, KS
- Domestic US shipping only
- Discreet packaging, no product names on external labels
- Questions? Email optilifewellness@polsia.app
Research Community Reviews
"Excellent purity. COA matched expectations. Will reorder."
Marcus T.Need reconstitution water?
Bacteriostatic water is required to reconstitute lyophilized peptides for research applications.
